三维监管枢纽支持质母细胞瘤的致癌方案
Sarah L Breves1,2,3, Dafne Campigli Di Giammartino1,3,4, James Nicholson5
1Sanford I. Weill Department of Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, United States.
bioRxiv : the preprint server for biology
|March 4, 2025
概括
研究人员在质母细胞干细胞 (GSC) 中确定了3D调节枢纽. 沉默这些枢纽扰乱了基因表达,减少了癌细胞的生长,揭示了大脑瘤中潜在的治疗点.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 3D核中的增强器-促进器通信对于基因调节至关重要.
- 这种沟通的失调与癌症的发展有关.
- 质母细胞干细胞 (GSCs) 为研究癌症调节网络提供了一个独特的模型.
研究的目的:
- 在患者衍生的GSCs与神经元干细胞 (NSCs) 中对3D增强器-促进器网络进行分析.
- 为了确定关键的监管枢纽和质母细胞瘤的漏洞.
- 调查这些枢纽在致癌计划中的作用.
主要方法:
- 3D基因组构造捕获技术用于绘制增强剂-促进剂相互作用.
- 单细胞RNA测序用于分析基因表达模式.
- 特定的调节枢纽的表观遗传操纵 (沉默).
- 综合癌症数据集的生物信息分析.
主要成果:
- 在GSC中确定了超连接的3D调控枢纽,与协调基因表达和瘤计划相关.
- 特定枢纽的表观遗传沉默导致了基因下调,改变了转录状态,并降低了GSC的克隆性.
- 在不同类型的癌症中发现了通用和癌症特异性枢纽,这些枢纽与不同的致癌途径有关.
- 遗传变化只解释了超连接枢纽活动的很小一部分.
结论:
- 三维监管枢纽在控制质母细胞瘤的致癌程序中发挥着核心作用.
- 这些中心代表了脑瘤的潜在治疗漏洞.
- 这项研究为识别癌症中关键的调节元素提供了一个框架.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K